Bioequivalence Study of WP205 in Healthy Participants

NCT07281872 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Therapeutic Equivalency, Healthy

Interventions

DRUG: Methylconalamin Injection(WP205)
DRUG: Methylconalamin for Injection

Sponsor

Wanbangde Pharmaceutical Group Co., LTD